Bessemer Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28K | Buy |
504
+318
| +171% | +$17.7K | ﹤0.01% | 1473 |
|
|
2025
Q1 | $9K | Sell |
186
-15
| -7% | -$726 | ﹤0.01% | 1825 |
|
|
2024
Q4 | $8K | Buy |
201
+107
| +114% | +$4.26K | ﹤0.01% | 1870 |
|
|
2024
Q3 | $4K | Buy |
+94
| New | +$4K | ﹤0.01% | 2031 |
|
|
2020
Q3 | – | Sell |
-53,500
| Closed | -$945K | – | 1606 |
|
|
2020
Q2 | $945K | Buy |
+53,500
| New | +$945K | ﹤0.01% | 813 |
|